| URL | https://www.biospace.com/article/releases/rls-expa |
| Source | BioSpace |
| Date Published | 10/26/2023 |
| Company/Division name | RLS Radiopharmacies |
| Parent company | RLS Radiopharmacies |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2023 |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | radioisotope, radiopharmaceutical drugs |
| What non-domestic negative factors made offshoring less attractive? | Supply chain interruption |
| What domestic positive factors made reshoring more attractive? | Skilled workforce availability/training, Under-utilized capacity |